Free Trial

Universe Pharmaceuticals (UPC) SEC Filings & 10K Form

Universe Pharmaceuticals logo
$4.65 -0.85 (-15.45%)
As of 03:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Universe Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/15/2025
5:07 PM
Anson Funds Management LP (Filed by)
Universe Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
03/20/2025
7:33 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
7:33 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:24 PM
Anson Funds Management LP (Filed by)
Universe Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/03/2025
3:10 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
7:00 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
7:30 AM
Universe Pharmaceuticals (Filer)
Form NT 20-F
01/03/2025
7:51 PM
SABBY MANAGEMENT, LLC (Filed by)
Universe Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/12/2024
3:31 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
7:02 AM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:00 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:05 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2024
3:05 PM
Universe Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2024
11:15 PM
Universe Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:UPC) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners